GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.3201
+0.0191 (6.35%)
At close: Aug 7, 2026, 4:00 PM EDT
0.3249
+0.0048 (1.50%)
Pre-market: Aug 10, 2026, 7:00 AM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $11.54 million as of August 10, 2026. Its market cap has increased by 156.53% in one year.
Market Cap
11.54M
Enterprise Value
2.62M
1-Year Change
156.53%
Ranking
Category
Stock Price
$0.32
ChartMarket Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $11.54M, a decrease of -86.13%. That is a compound annual growth rate of -21.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 11.50M | 38.55% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 13.11M |
| Akari Therapeutics, | 12.25M |
| Phio Pharmaceuticals | 12.08M |
| Vistagen Therapeutics | 11.80M |
| Kiora Pharmaceuticals | 11.68M |
| Instinct Bio Technical Company Holdings | 11.56M |
| Intensity Therapeutics | 11.24M |
| BioCardia | 11.13M |